1-in-17 kids who get COVID-19 have lingering symptoms 90 days later

Embargoed until: Publicly released: 2022-07-23 01:00

International

CC-0

Around one-in-17 kids who get COVID-19 have lingering symptoms 90 days later, according to international scientists. The team looked at health records for 3,387 kids, 1,886 of who had had COVID-19, and found 5.8% of patients (including 9.8% of hospitalised children and 4.6% of discharged children) reported post-COVID-19 conditions, such as respiratory problems (cough, difficulty breathing or shortness of breath) and fatigue or weakness. The kids most likely to have lingering symptoms were those aged 14 years or older, those who were hospitalised for 48 hours or more, and those who had four or more symptoms initially. The team says their findings suggest guidance and follow-up are particularly necessary for hospitalised children with numerous acute symptoms who are 14 or older.

Media release

From: JAMA

Post–COVID-19 Conditions Among Children 90 Days After SARS-CoV-2 Infection

About The Study: In this study of 1,884 SARS-CoV-2-positive children with 90-day follow-up, 5.8% of patients (including 9.8% of hospitalized children and 4.6% of discharged children) reported post-COVID-19 conditions, such as respiratory (cough, difficulty breathing or shortness of breath) and systemic (fatigue or weakness). Guidance and follow-up are particularly necessary for hospitalized children who have numerous acute symptoms and are older.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page The URL will go live after the embargo ends

Journal/
conference: JAMA Network Open

Research:Paper

Organisation/s: University of Calgary, Canada

Funder: This studywas supported by grants from the Canadian Institutes of Health Research (operating grant: COVID-19–clinical management); the Alberta Health Services–University of Calgary–Clinical Research Fund; the Alberta Children’s Hospital Research Institute; the COVID-19 Research Accelerator Funding Track (CRAFT) Program at the University of California, Davis; and the Cincinnati Children’s Hospital Medical Center Division of Emergency Medicine Small Grants Program. Dr Funk is supported by the University of Calgary Eyes-High Post- Doctoral Research Fund. Dr Freedman is supported by the Alberta Children’s Hospital Foundation Professorship in Child Health andWellness.

Media Contact/s

Contact details are only visible to registered journalists.